IL1R1 and acute kidney injury: Our study reveals for the first time that the treatment of RA significantly decreases the level of upregulated HMGB1, TLR-4, MyD88 and IL-1R1 proteins in CP-induced AKI offering a molecular mechanism of RA-induced protection against CP toxicity.